6144 POSTER Phase II Study of Panitumumab With Irinotecan for Patients With KRas Wild-type Metastatic Colorectal Cancer (MCRC) Refractory to Standard Chemotherapy – a GERCor Study

✍ Scribed by Andre, T.; Chibaudel, B.; Mabro, M.; Bennamoun, M.; Artru, P.; Bachet, J.B.; Hadengue, A.; Blons, H.; Laurent-Puig, P.; de Gramont, A.

• Book ID: 121896748
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 45 KB
• Volume: 47
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(11)71789-0